Skip to content
lifestyle.gopreneurs.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Apotex Inc.
Apotex Expands Canadian Ophthalmology Portfolio with Health Canada’s Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)
March 25, 2026
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 13, 2026
Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal
February 11, 2026
←
Previous Page
1
2